DIGENE About
DIGENE Digene Corporation develops, manufactures and
markets proprietary gene-based testing systems for the screening, monitoring and
diagnosis of human diseases. DIGENE'S primary focus is in women’s cancers and
infectious diseases. Their proprietary Hybrid Capture® technology has been used
to a successful diagnostic test for human papillomavirus,
or HPV, which is the primary cause of cervical
cancer and is found in greater than 99% of all cervical cancer cases.
About the Hybrid Capture Technology More
on DIGENE